DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
Salbutamol WZF 4 mg ( DrugBank:
Salbutamol
)
1 disease
告示番号
疾患名
(ページ内リンク)
臨床試験数
11
重症筋無力症
1
11. 重症筋無力症
臨床試験数
:
332
/
薬物数
:
234
- (
DrugBank
:
81
) /
標的遺伝子数
:
45
-
標的パスウェイ数
:
127
10
50
100
ALL
diseases per page:
Showing 1 to 1 of 1 diseases
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
EUCTR2019-000895-40-DK
(
EUCTR
)
28/03/2019
26/02/2019
Beta-agonist Efficacy and Tolerability as Adjuvant therapy in Myasthenia Gravis
Beta-agonist Efficacy and Tolerability as Adjuvant therapy in Myasthenia Gravis - BETA-MG
Myasthenia Gravis
MedDRA version: 21.1;Level: PT;Classification code 10028417;Term: Myasthenia gravis;System Organ Class: 10029205 - Nervous system disorders;Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]
Myasthenia Gravis
MedDRA version: 21.1;Level: PT;Classification code 10028417;Term: Myasthenia gravi ...
Trade Name:
Salbutamol WZF 4 mg
INN or Proposed INN: Salbutamol
Other descriptive name: SALBUTAMOL SULFATE PH. EUR.
Trade Name:
Salbutamol WZF 4 mg
INN or Proposed INN: Salbutamol
Other descriptive name: SALBUTAMOL SUL ...
Aarhus University Hospital
NULL
Authorised-recruitment may be ongoing or finished
Female: yes
Male: yes
30
Phase 3
Denmark